BioNexus Gene Lab Corp. Proceeds from (Repayments of) Other Debt
BioNexus Gene Lab Corp. (BGLC) reported Proceeds from (Repayments of) Other Debt of $0 for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfOtherDebt · last filed 2022-05-16
- BioNexus Gene Lab Corp. proceeds from (repayments of) other debt for the quarter ending 2022-03-31 was $0.00.
- BioNexus Gene Lab Corp. proceeds from (repayments of) other debt for the quarter ending 2021-09-30 was -$6.00K, a 418.99% decline year-over-year.
- BioNexus Gene Lab Corp. proceeds from (repayments of) other debt for the quarter ending 2021-06-30 was -$6.80K.
- BioNexus Gene Lab Corp. proceeds from (repayments of) other debt for the quarter ending 2021-03-31 was -$8.55K.
| Period end | Proceeds from (Repayments of) Other Debt 3 month | Proceeds from (Repayments of) Other Debt 6 month | Proceeds from (Repayments of) Other Debt 6 month as first filed | Proceeds from (Repayments of) Other Debt 9 month | Proceeds from (Repayments of) Other Debt 9 month as first filed |
|---|---|---|---|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | ||||
| 2021-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$12.79K derived: sum of 2 quarters · filed 2021-11-15 | -$21.34K 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | -$6.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$15.35K 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | -$8.55K 10-Q · filed 2022-05-16 | ||||
| 2020-09-30 | $1.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$732.00 derived: sum of 2 quarters · filed 2021-11-15 | -$7.13K 10-Q · filed 2021-11-15 | -$5.90K 10-Q · filed 2020-11-03 | |
| 2020-06-30 | -$2.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$9.01K 10-Q · filed 2021-08-12 | -$7.60K 10-Q · filed 2020-08-11 | ||
| 2020-03-31 | -$6.40K 10-Q · filed 2021-05-18 | ||||
| 2019-09-30 | -$5.53K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2020-11-09 | -$13.45K 10-Q/A · filed 2020-11-09 | |||
| 2019-06-30 | -$7.92K 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |